Patents Represented by Attorney Bradford R.L. Price
  • Patent number: 5947692
    Abstract: A controller for a peristaltic pump receives as an input pressure P.sub.i sensed at the inlet of the pump. The controller derives a nonlinear scale factor S.sub.Pi that varies as a step function with P.sub.i. The scale factor S.sub.Pi equals a first nonvariable value when P.sub.i lays in a first defined zone of inlet pressures, and equals a second nonvariable value, different than the first nonvariable value, when P.sub.i lays in a second defined zone of inlet pressures different than the first defined zone of inlet pressures. The controller generates a pump speed command based, at least in part, upon S.sub.Pi.
    Type: Grant
    Filed: October 30, 1997
    Date of Patent: September 7, 1999
    Assignee: Baxter International Inc.
    Inventors: Mark P Sahlin, Timothy J Patno
  • Patent number: 5935092
    Abstract: Systems and methods treat plasma carrying contaminants and leukocytes that are capable of entraining contaminants. The systems and methods separate leukocytes from the plasma by filtration, thereby removing contaminants entrained within leukocytes. The systems and methods also add to the plasma a photoactive material and emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by leukocytes.
    Type: Grant
    Filed: December 19, 1995
    Date of Patent: August 10, 1999
    Assignee: Baxter International Inc.
    Inventors: Chong-Son Sun, John Chapman, Daniel F. Bischof, Robert E. Herman
  • Patent number: 5922278
    Abstract: Apparatus and methods for treating a biological fluid with light and for inactivating contaminants in biological fluid. The biological fluid is contacted with a light source providing a high intensity light to the biological fluid. The biological fluid may include a quantity of a photochemical agent that when activated by light is operable to cause inactivation of at least some of the contaminants.
    Type: Grant
    Filed: November 19, 1996
    Date of Patent: July 13, 1999
    Assignee: Baxter International Inc.
    Inventors: John R. Chapman, Peter R. H. Stark, Michael A. Reed, Dale N. Larson, Daniel F. Cuffaro
  • Patent number: 5916743
    Abstract: A method combining the techniques of immunoaffinity separation and continuous flow centrifugal separation is provided for selective separation of a nucleated heterogeneous cell population from a heterogeneous cell mixture. The heterogeneous cell mixture is intimately contacted to promote binding thereto by particles having attached a substance that actively binds to a specific desired type of cell out of the cell mixture. The particles are selected so that the sedimentation velocity of the particle/cell conjugate differs sufficiently from those of other cells in the cell mixture to allow its separation by means of a continuous flow cell separator.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 29, 1999
    Assignee: Baxter International Inc.
    Inventors: William C. Lake, Richard Giesler, Dennis Van Epps, John R. Chapman, Jeffrey A. Martinson, Dale R. Ellis, Frederick Aono, Daniel F. Bischof
  • Patent number: 5906598
    Abstract: A drip chamber includes a cap that extends the field of view of a droplet in a vertical direction above the plane of the droplet, as well as horizontally in the plane of the droplet. The drip chamber has a deformable body and an interior volume to accommodate manual air purging and priming by squeezing the body.
    Type: Grant
    Filed: November 22, 1995
    Date of Patent: May 25, 1999
    Assignee: Baxter International Inc.
    Inventors: Richard C. Giesler, Dale R. Ellis, Mark R. Vandlik
  • Patent number: 5906915
    Abstract: The present invention provides an improved aqueous solution for suspending and storing red blood cells. The solution includes sodium citrate, a combination of sodium biphosphate and sodium phosphate dibasic, adenine, and mannitol. The solution is formulated at a low osmolarity and has a physiological pH of approximately 7.4. The solution simultaneously maintains stored red cells ATP and 2,3-BPG. Also disclosed is a method for storing red blood cells comprising adding an anticoagulant with a reduced citrate concentration compared to a CPD solution comprising 26.3 g/l, sodium citrate and 3.28 g/l citric acid hydrous to whole blood, separating the red cells and adding a storage solution comprising sodium citrate, sodium diphosphate, sodium phosphate dibasic, adenine and mannitol.
    Type: Grant
    Filed: October 31, 1996
    Date of Patent: May 25, 1999
    Assignee: Baxter International Inc.
    Inventors: Jean-Marc Payrat, Claes F. Hogman, Jack DeBrauwere, Jean Marie Mathias
  • Patent number: 5885457
    Abstract: The invention provides a leukodepletion filter including a plurality of glass fiber filter pads, and a plurality of non-woven polyester fiber filter pads, sealed within a filter housing.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: March 23, 1999
    Assignee: Baxter International Inc.
    Inventors: Julian P. Breillatt, Jr., Sharon L. Pokropinski
  • Patent number: 5868696
    Abstract: A peristaltic pump tube holder includes a body that supports a flexible tubing loop in an erect, outwardly bowed position extending from the body for engagement with a peristaltic pump rotor. The holder also includes a receptacle carrying the body. The receptacle includes a wall forming a chamber that covers the flexible tubing loop and at least partially shields it from contact. The chamber further serves, during engagement between the tubing loop and a peristaltic pump rotor, as a cover for the peristaltic pump rotor.
    Type: Grant
    Filed: April 28, 1997
    Date of Patent: February 9, 1999
    Assignee: Baxter International Inc.
    Inventors: Richard C. Giesler, Myra P. Miles, Susan L. Lovelace, Timothy J. Patno, Richard L. West
  • Patent number: 5869701
    Abstract: Viral and bacterial contaminants present in biological solutions are inactivated by mixing one of a novel class of photosensitizer with said solution and irradiating the mixture.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: February 9, 1999
    Assignee: Baxter International Inc.
    Inventors: Sang Chul Park, Raymond P. Goodrich, Jr., Nagender Yerram, Samuel O. Sowemimo-Coker, Matthew S. Platz, Brian M. Aquila
  • Patent number: 5865785
    Abstract: Blood processing systems and methods establish on line communication between a container and a source of blood containing leukocytes and platelets, such as a human donor. The systems and methods create a centrifugal field between the source of blood and the container that separates from the blood an unfinished suspension of platelets having a first physiologic characteristic different than the desired physiologic characteristic. The systems and methods pump the unfinished platelet suspension outside the centrifugal field through a finishing device. The finishing device changes the first physiologic characteristic to the desired physiological characteristic, thereby creating the finished platelet suspension. The systems and methods convey the finished platelet suspension from the finishing device directly into the container. The systems and methods function without interrupting the on line communication between the container and the source of blood.
    Type: Grant
    Filed: February 23, 1996
    Date of Patent: February 2, 1999
    Assignee: Baxter International Inc.
    Inventor: Daniel F. Bischof
  • Patent number: 5866074
    Abstract: A vessel holds a liquid content for exposure to prescribed light energy. The vessel has a region transparent to the prescribed light energy. The liquid content of the vessel includes a solution comprising a material undergoing reduction oxidation as a result of exposure to the prescribed light energy, and a reducing agent for the photoactive material. A device measures optical absorbance of the vessel and the liquid content. The device operates in a first instance to measure a first optical absorbance value before exposing the vessel and the liquid content to the prescribed light energy. The device also operates in a second instance to measure a second optical absorbance value after exposing the vessel and the liquid content to the prescribed light energy, to obtain a difference between the first and second optical absorbance values. The difference comprises an illumination characteristic for the vessel with respect to the prescribed light energy.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: February 2, 1999
    Assignee: Baxter International Inc.
    Inventors: John R. Chapman, Jean M. Mathias
  • Patent number: 5858016
    Abstract: An aseptic/sterile fluid connection between two containers is formed by radio frequency sealing together portions of transfer regions of two containers. Each transfer region has a layer of a relatively high melt temperature material such as a rubber or elastomer positioned between two outer container walls made of a flexible thermoplastic, for example polyvinyl chloride. The transfer regions are placed in registry, and the radio frequency welding fuses together portions of adjacent container outer walls and forms a fluid opening therethrough.
    Type: Grant
    Filed: July 14, 1992
    Date of Patent: January 12, 1999
    Assignee: Baxter International Inc.
    Inventors: David Bacehowski, David Cerny, Dean Glash, Richard Afflerbaugh, Joseph West, Jr.
  • Patent number: 5849203
    Abstract: Methods of separating selected blood components separate blood by centrifugation in a rotating chamber into a first separated blood component, a residual blood fluid, and an interface between the first separated blood component and the residual blood fluid. The methods withdraw the first separated blood component out of the rotating chamber through a first outlet port, and withdraw the residual blood fluid out of the rotating chamber through a second outlet port. During the separation step, the methods accumulate a second separated blood component in the interface without withdrawal from the rotating chamber by controlling the position of the interface within the rotating chamber at a location spaced away from flow communication with both the first and second outlet ports.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: December 15, 1998
    Assignee: Baxter International Inc.
    Inventors: Richard I. Brown, Sidney Smith, David E. Cerny, John T. Foley
  • Patent number: 5836934
    Abstract: A blood processing system and associated method include a first variable volume chamber to hold blood and a second variable volume chamber to hold additive solution for blood. The system and method further employ a separation device to remove undesired material from blood. An actuated element exerts external force simultaneously upon both first and second variable volume chambers to expel a first flow of blood from the first variable volume chamber and a second flow of additive solution from the second variable volume chamber. The system and method mix outside the first and second variable volume chambers the blood flow with the flow of additive solution to create a mixed flow comprising blood and additive solution. The system and method direct the mixed flow of blood and additive solution through a filter to remove undesired matter from the blood.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 17, 1998
    Assignee: Baxter International Inc.
    Inventor: Richard Beshel
  • Patent number: 5833866
    Abstract: Systems and methods for separating platelets from blood derive the yield of platelets in real time as processing is accomplished. The systems and method determine an incremental blood volume processed during a succession of incremental time periods during the separation step. The systems and methods also estimate a separation efficiency for the separation device during each incremental time period, while also estimating a current count of platelets available from the donor during each incremental time period. The systems and methods multiply the determined incremental blood volume for each incremental time period by the estimated current count of platelets for each incremental time period by the estimated separation efficiency for each incremental time period, to derive an incremental platelet yield for each incremental time period. The systems and methods sum the incremental platelet yields over the succession of incremental time periods to obtain the derived yield of platelets.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: November 10, 1998
    Assignee: Baxter International Inc.
    Inventor: Richard I. Brown
  • Patent number: 5824216
    Abstract: A container for housing body fluids, preferably blood in its component form. The container comprises a body defined by flexible walls having an interior for housing the body fluid. Additionally, a means for allowing selective fluid flow allows the blood components to be expressed from one chamber of the container into another to separate and separately house the blood components. The present invention also provides a method for separating blood into its components and individually storing same.
    Type: Grant
    Filed: May 17, 1996
    Date of Patent: October 20, 1998
    Assignee: Baxter International Inc.
    Inventors: Michel Joie, Jack Debrauwere, Jean-Claude Bernes, Richard Goldhaber
  • Patent number: 5811061
    Abstract: A method and apparatus for creating a leukocyte rich sample from a mixed population of blood cells. The method comprises the steps of: separating an amount of blood into layers that include a buffy coat layer having a mixed population of blood cells including plasma and red blood cells; providing a chamber having an opening for receiving a fluid; causing the buffy coat layer to enter the chamber; centrifuging the chamber to separate the buffy coat layer into at least a plasma containing layer, a leukocyte containing layer, and a red blood cell containing layer; and separating the leukocyte containing layer from the other layers in the chamber.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: September 22, 1998
    Assignee: Baxter International Inc.
    Inventors: Jeffrey Martinson, William Bratten, Li Ming Wang, John Chapman
  • Patent number: 5807492
    Abstract: Blood separation systems and methods separate mono nuclear cells from whole blood. The systems and methods introduce whole blood into a rotating chamber for separation into red blood cells, a plasma constituent, and an interface carrying mono nuclear cells between the red blood cells and the plasma constituent. The systems and methods convey whole blood into the chamber while removing red blood cells and the plasma constituent and while maintaining the interface at a set location within the chamber. At an appropriate processing time, the systems and methods move the interface from the set location for removal from the chamber through an outlet path. The outlet path includes a sensing element to locate mono nuclear cells in the outlet path outside the chamber.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: September 15, 1998
    Assignee: Baxter International Inc.
    Inventors: Richard I. Brown, Kyungyoon Min
  • Patent number: 5804079
    Abstract: Systems and methods separate whole blood containing leukocytes in a first separation chamber into a first layer comprising red blood cells, a second layer comprising a suspension of platelets, and an interface between the first and second layers. The systems and methods convey the suspension of platelets into a second separation chamber while simultaneously filtering the suspension of platelets to reduce the number of leukocytes. The systems and methods separate the filtered suspension of platelets in the second separation chamber into a platelet-rich concentrate and platelet-poor component.
    Type: Grant
    Filed: September 24, 1996
    Date of Patent: September 8, 1998
    Assignee: Baxter International Inc.
    Inventor: Richard I. Brown
  • Patent number: 5795483
    Abstract: Novel blood cell fractionation means utilizes conventional filters coated with high molecular weight polyethylene oxide derivatives crosslinked to prevent leaching from filter surfaces. These fractionation means have a special efficacy in binding white blood cells from whole blood while simultaneously allowing red cells and platelets to pass in the effluent phase.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: August 18, 1998
    Assignee: Baxter International Inc.
    Inventors: Neng S. Ung-Chhun, Richard J. Johnson